Pure Mucinous Carcinoma of the Breast: a Clinicopathologic Analysis with 56 Patients
中国医学科学杂志(英文版)2010年第2期 页码:115-118
• Original Article •|Updated:2024-04-10
|
Share with wechat friends or circle of friends
Export references
Pure Mucinous Carcinoma of the Breast: a Clinicopathologic Analysis with 56 Patients
Affiliations:
1. Department of Breast Surgery
2. Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College,Beijing,China,100730
Author bio:
Funds:
DOI:
中图分类号:
网络出版日期:2010-06-10,
纸质出版日期:2010
Accepted:
Scan QR Code
Li Peng, Qiang Sun, Zhi-yong Liang, 等. Pure Mucinous Carcinoma of the Breast: a Clinicopathologic Analysis with 56 Patients[J]. 中国医学科学杂志(英文版), 2010,(2):115-118.
Li Peng, Qiang Sun, Zhi-yong Liang, et al. Pure Mucinous Carcinoma of the Breast: a Clinicopathologic Analysis with 56 Patients[J]. Chinese medical sciences journal, 2010, (2): 115-118.
Li Peng, Qiang Sun, Zhi-yong Liang, 等. Pure Mucinous Carcinoma of the Breast: a Clinicopathologic Analysis with 56 Patients[J]. 中国医学科学杂志(英文版), 2010,(2):115-118.DOI:
Li Peng, Qiang Sun, Zhi-yong Liang, et al. Pure Mucinous Carcinoma of the Breast: a Clinicopathologic Analysis with 56 Patients[J]. Chinese medical sciences journal, 2010, (2): 115-118.DOI:
Pure Mucinous Carcinoma of the Breast: a Clinicopathologic Analysis with 56 Patients
Objective To assess recent trends and prognostic features in the treatment of pure mucinous carcinoma (PMC) of the breast. Methods Fifty-six patients diagnosed with PMC of the breast in our hospital from December 1982 to June 2008 were included. We evaluated the general information and tumor characteristics of the patients
examined the relationship between these factors and prognosis. Fisher's exact test was applied to analyze tumor characteristics. Results The mean age of the patients was 53.7 years. The majority of the patients presented with early stage disease. Tumor size was found not a significant prognostic factor in this study. Mean follow-up period was 39 months and no breast cancer-related deaths were identified in the patient cohort. Conclusions PMC of the breast has a favorable prognosis. Tumor size does not appear to significantly impact survival.
Abstract
Objective To assess recent trends and prognostic features in the treatment of pure mucinous carcinoma (PMC) of the breast. Methods Fifty-six patients diagnosed with PMC of the breast in our hospital from December 1982 to June 2008 were included. We evaluated the general information and tumor characteristics of the patients
examined the relationship between these factors and prognosis. Fisher's exact test was applied to analyze tumor characteristics. Results The mean age of the patients was 53.7 years. The majority of the patients presented with early stage disease. Tumor size was found not a significant prognostic factor in this study. Mean follow-up period was 39 months and no breast cancer-related deaths were identified in the patient cohort. Conclusions PMC of the breast has a favorable prognosis. Tumor size does not appear to significantly impact survival.
ESTROGEN RECEPTOR-NEGATIVE BREAST CANCER CELLS TRANSFECTED WITH ESTROGEN RECEPTOR EXHIBIT DECREASED TUMOUR PROGRESSION AND SENSITIVITY TO GROWTH INHIBITION BY ESTROGEN
THE CORRELATIONS OF CLINICOPATHOLOGIC FEATURES, HORMONE RECEPTOR LEVEL WITH THE PROGNOSIS OF BREAST CANCER: REPORT OF 308 CASES IN ELDERLY WOMEN
CORRELATION BETWEEN SERUM HER-2 ONCOPROTEIN AND PATIENTS WITH BREAST CANCER
PREDICTION OF NON-SENTINEL LYMPH NODE METASTASES IN BREAST CANCER
KNOCKDOWN OF SURVIVIN EXPRESSION BY SMALL INTERFERING RNA SUPPRESSES PROLIFERATION OF TWO HUMAN CANCER CELL LINES